329 related articles for article (PubMed ID: 26980765)
1. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).
Tsuchihashi K; Okazaki S; Ohmura M; Ishikawa M; Sampetrean O; Onishi N; Wakimoto H; Yoshikawa M; Seishima R; Iwasaki Y; Morikawa T; Abe S; Takao A; Shimizu M; Masuko T; Nagane M; Furnari FB; Akiyama T; Suematsu M; Baba E; Akashi K; Saya H; Nagano O
Cancer Res; 2016 May; 76(10):2954-63. PubMed ID: 26980765
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration.
Wolf IM; Fan Z; Rauh M; Seufert S; Hore N; Buchfelder M; Savaskan NE; Eyüpoglu IY
Sci Rep; 2014 Sep; 4():6226. PubMed ID: 25228443
[TBL] [Abstract][Full Text] [Related]
6. Autocrine glutamate signaling promotes glioma cell invasion.
Lyons SA; Chung WJ; Weaver AK; Ogunrinu T; Sontheimer H
Cancer Res; 2007 Oct; 67(19):9463-71. PubMed ID: 17909056
[TBL] [Abstract][Full Text] [Related]
7. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
8. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W
Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
[TBL] [Abstract][Full Text] [Related]
10. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.
Sleire L; Skeie BS; Netland IA; Førde HE; Dodoo E; Selheim F; Leiss L; Heggdal JI; Pedersen PH; Wang J; Enger PØ
Oncogene; 2015 Dec; 34(49):5951-9. PubMed ID: 25798841
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen peroxide triggers an increase in cell surface expression of system x
Chase LA; VerHeulen Kleyn M; Schiller N; King AG; Flores G; Engelsman SB; Bowles C; Smith SL; Robinson AE; Rothstein J
Neurochem Int; 2020 Mar; 134():104648. PubMed ID: 31874187
[TBL] [Abstract][Full Text] [Related]
13. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
[TBL] [Abstract][Full Text] [Related]
14. Glial Glutamate Transporter-Mediated Plasticity: System x
Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
[TBL] [Abstract][Full Text] [Related]
15. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC
Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species involved in the glutamate toxicity of C6 glioma cells via xc antiporter system.
Mawatari K; Yasui Y; Sugitani K; Takadera T; Kato S
Neuroscience; 1996 Jul; 73(1):201-8. PubMed ID: 8783242
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
Otsuki Y; Yamasaki J; Suina K; Okazaki S; Koike N; Saya H; Nagano O
Cancer Sci; 2020 Jan; 111(1):127-136. PubMed ID: 31692172
[TBL] [Abstract][Full Text] [Related]
18. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
19. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
20. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]